Of the 40 recertification units (RUs) required for a CRNI® to recertify, at least 30 RUs must be obtained by attending any INS Meeting (live or online). Up to 10 RUs may be earned from the non INS Meeting category. The learning assets in this section have all been approved for RUs. Virtual Conferences meet the INS Meeting criteria. Webinars meet the non INS Meeting criteria. All webinars are free to INS members.

CRNI® Recertification Approved

Search by Category
Search by Format
Sort By
Search by Keyword
  • Contains 6 Product(s)

    This Infusion Nurses Society virtual symposium addresses error causation, including the impact of human factors, the hazards within medication preparation and administration, the risk of medication errors with infusion pumps, the effects of an adverse event upon the clinician, and the use of teamwork as a foundation for safety. The propensity of humans to err causes us to continually strive to find ways to minimize errors when infusing medications. Additionally, the COVID-19 pandemic has impacted the risk for errors due to staff shortages, concern about exposure to the virus, the emotional and physical stress of providing patient care, and the way patient care is delivered. This program offers new perspectives on preventing patient harm, supporting health care clinicians, and developing organizational safety systems.

    This Infusion Nurses Society virtual symposium addresses error causation, including the impact of human factors, the hazards within medication preparation and administration, the risk of medication errors with infusion pumps, the effects of an adverse event upon the clinician, and the use of teamwork as a foundation for safety. The propensity of humans to err causes us to continually strive to find ways to minimize errors when infusing medications. Additionally, the COVID-19 pandemic has impacted the risk for errors due to staff shortages, concern about exposure to the virus, the emotional and physical stress of providing patient care, and the way patient care is delivered. This program offers new perspectives on preventing patient harm, supporting health care clinicians, and developing organizational safety systems.

  • Contains 3 Component(s) Includes a Live Web Event on 10/05/2022 at 1:00 PM (EDT)

    Gout is a type of arthritis that occurs when extra uric acid in the body forms crystals in the joints, causing pain and swelling. Early diagnosis and treatment of gout are important to prevent complications. During this presentation, the presenter will provide an overview of gouty arthritis, discuss the patient’s journey, and elaborate on the principles and guidelines for the management of gout as well as on the associated comorbidities.

    image

    Gout is a type of arthritis that occurs when extra uric acid in the body forms crystals in the joints, causing pain and swelling. Early diagnosis and treatment of gout are important to prevent complications. During this presentation, the presenter will provide an overview of gouty arthritis, discuss the patient’s journey, and elaborate on the principles and guidelines for the management of gout as well as on the associated comorbidities.

    Learning Objectives: At the conclusion of this session, the learner will be able to:
    1. Define the disease state of gout
    2. Discuss the pathophysiology of gout
    3. Review principles of disease management

    *There are no Contact Hours or Recertification Units provided for this webinar

    Vikram Garg, MD

    Vikram Garg, MD, is a board-certified physician in internal medicine, rheumatology, and musculoskeletal ultrasound. He has over six years of direct patient care and teaching experience with assessment and treatment of all rheumatic conditions including rheumatoid arthritis, lupus, and gout.

  • Contains 3 Component(s), Includes Credits Recorded On: 09/14/2022

    Iron deficiency anemia (IDA) is a common diagnosis which occurs when body iron stores fall below the necessary levels to maintain steady state hemoglobin. IDA can be categorized into two main causes, low iron input (inadequate dietary intake or malabsorption) or increased iron output (usually from blood loss and rarely with urinary iron loss such as in nephrotic syndrome).

    image

    Iron deficiency anemia (IDA) is a common diagnosis which occurs when body iron stores fall below the necessary levels to maintain steady state hemoglobin. IDA can be categorized into two main causes, low iron input (inadequate dietary intake or malabsorption) or increased iron output (usually from blood loss and rarely with urinary iron loss such as in nephrotic syndrome). 

    The topic of discussion will include basics of interpreting common labs used for diagnosing anemia including complete blood count (CBC), iron panel (including ferritin), B12/Folate, and lactate dehydrogenase (LDH) to help differentiate iron deficiency anemia from other causes such as anemia of chronic disease, bone marrow suppression from drugs, chronic kidney disease, or chronic hemolysis. First line treatment for iron deficiency anemia is often oral iron supplements, but when patient has a lack of response, or an intolerance to oral iron, IV iron infusions can restore the iron deficit. During this webinar, we will discuss the causes of IDA, the symptoms of IDA, safe IV iron infusion administration, and potential complications of IV iron infusions.

    Learning Objectives: At the conclusion of this session, learners will be able to:

    1. Interpret commons labs used to differentiate iron deficiency anemia from other causes of anemia
    2. Describe the causes of and symptoms of IDA
    3. Review common treatment algorithms for treatment of iron deficiency
    4. Recognize the indications for intravenous iron replacement
    5. Discuss process for safe IV iron infusion administration
    6. Review common potential complications of iron administration and appropriate interventions

    Dr. Christopher Chen

    Dr. Christopher Chen received his undergraduate degree from Washington University in St. Louis with a BA in finance and biology. He then received both his medical degree and an MBA from the State University of New York at Buffalo after which he completed his residency and fellowship at the University of Arizona, Tucson. He is board certified in internal medicine, hematology, and oncology, and has been a preceptor for both the medical school and residency programs in Tucson since 2019.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: September14, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits

    ​The United States is in the midst of the opioid epidemic which has claimed more lives in 2021 than in any previous year. The epidemic is being fueled by potent synthetic opioids and at the same time a rising use of methamphetamine with more dangerous sequelae due to the changes in production. Nurses in all settings will care for individuals who may be experiencing pain but also may be using substances that jeopardize their health. In this session an overview of approaches to pain management will be outlined. The presenter will describe the use of trauma-informed care and harm reduction principles as a basis for providing compassionate care to this vulnerable population.

    The United States is in the midst of the opioid epidemic which has claimed more lives in 2021 than in any previous year.  The epidemic is being fueled by potent synthetic opioids and at the same time a rising use of methamphetamine with more dangerous sequelae due to the changes in production.  Nurses in all settings will care for individuals who may be experiencing pain but also may be using substances that jeopardize their health. In this session an overview of approaches to pain management will be outlined.  The presenter will describe the use of trauma-informed care and harm reduction principles as a basis for providing compassionate care to this vulnerable population.

    Learning Objectives:  At the conclusion of this presentation, learners will be able to:

    1.     Describe substance use disorders and relation to pain

    2.     Gain insight into relevance of trauma-informed care in the health care setting

    3.     Discuss elements of harm reduction relevant to work with patients across the continuum

    4.     Describe general approaches utilized to manage pain in the setting of comorbid substance use disorder

    Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN, FAANP

    Kathleen Broglio is an associate professor of medicine at Geisel School of Medicine at Dartmouth College and a nurse practitioner in palliative medicine at Dartmouth Hitchcock Medical Center. Her studies have included the prevalence of opioid risk in oncology; cannabis use in palliative medicine; implementation of opioid management guidelines in palliative care; and interprofessional education in palliative and hospice. Kathleen’s clinical care focuses on complex pain management and treatment of substance use disorder in patients with serious illness. She mentors clinicians, lectures and has published on the treatment of pain in the setting of risks for substance use disorder. Her experience includes acute and chronic pain management; and acute, ambulatory, and home-based palliative care. She completed her Doctorate in Nursing Practice at New York University; a Palliative Care Fellowship at Beth Israel Medical Center, New York; a master’s in nursing at University of Washington, Seattle; a bachelor’s in nursing at University of Hawaii; and a bachelor’s in economics at University of Maryland.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: August 16, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 07/06/2022

    ​With the growing recognition of the infection risks of peripheral intravenous catheters (PIVC), many hospitals are implementing PIVC insertion and maintenance bundles. This presentation will review the evidence for PIVC bundles, discuss the essential components for such a bundle, explore implementation challenges, and emphasize compliance strategies. Infusion nurses who are considering implementing a PIVC insertion or maintenance bundle will benefit from this presentation.

    With the growing recognition of the infection risks of peripheral intravenous catheters (PIVC), many hospitals are implementing PIVC insertion and maintenance bundles. This presentation will review the evidence for PIVC bundles, discuss the essential components for such a bundle, explore implementation challenges, and emphasize compliance strategies. Infusion nurses who are considering implementing a PIVC insertion or maintenance bundle will benefit from this presentation.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    1.     Describe the common reasons for PIVC failure and the prevalence of PIVC bloodstream infection.

    2.     Review the history and rationale of the evidence-based bundle for bloodstream infection reduction.

    3.     Discuss the rationale for implementing a PIVC insertion and maintenance bundle.

    4.     Identify bundle components which have demonstrated reductions in PIVC–related bloodstream infection and other adverse events.

    5.     Discuss the challenges of bundle implementation and possible strategies to achieve compliance.

    Gillian Ray-Barruel, PhD, RN

    Senior Research Fellow

    University of Queensland School of Nursing, Midwifery, and Social Work

    Gillian Ray-Barruel, PhD, RN, is a senior research fellow with the University of Queensland School of Nursing, Midwifery, and Social Work and the Herston Infectious Diseases Institute (HeIDI), and an adjunct senior research fellow with Griffith University in Brisbane, Australia. She is also the education director for the Alliance for Vascular Access Teaching and Research (AVATAR). An experienced critical care nurse for 20 years, Dr. Ray-Barruel moved into vascular access research over 10 years ago and has published over 60 journal articles. Her research focuses on improving assessment and decision-making by clinicians to prevent device-related patient complications and to improve health care outcomes.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: July 6, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 06/15/2022

    ​Management of hypersensitivity infusion reactions (IRs) with H1-antihistamine premedication and/or treatment is recommended for several biologics and chemotherapies used in infusion centers. The sole second-generation intravenous H1-antihistamine recommended is cetirizine. In this session, the presenter will review key clinical data available with IV cetirizine as well as clinical profiles of first- and second-generation H1 antihistamines used to manage infusion reactions.

    image

    Management of hypersensitivity infusion reactions (IRs) with H1-antihistamine premedication and/or treatment is recommended for several biologics and chemotherapies used in infusion centers. The sole second-generation intravenous H1-antihistamine recommended is cetirizine. In this session, the presenter will review key clinical data available with IV cetirizine as well as clinical profiles of first- and second-generation H1 antihistamines used to manage infusion reactions.

    Learning Objectives: At the conclusion of this webinar, learners will be able to: 

    • Explain various infusion reactions and antihistamine use

    • Determine infusion reactions requiring a H1-antihistamine to treat a reaction or to prevent future reactions

    • Describe the use of IV H1-antihistamines

    • Determine which treatment options are the most appropriate for certain patients

    Ryan Haumschild, PharmD, MS, MBA

    Ryan Haumschild, PharmD, MS, MBA, is an experienced director of pharmacy, overseeing profit and loss responsibility, pharmacy operations, clinical services, formulary management, payer and health plan contracting, and medication use at the Winship Cancer Institute at Emory University, one of the nation’s largest academic integrated delivery networks and Georgia’s only National Cancer Institute (NCI)–designated comprehensive cancer center. Dr. Haumschild provides strategic direction on oncology and nononcology disease states, on infusion and specialty pharmacy services, and on the expansion of clinical services through treatment pathway development. He currently serves as an editorial board member at the American Journal of Managed Care® (AJMC®) and as a board member for the Institute of Safe Medication Practices (ISMP) and for the Center for Biosimilars, and was recently recognized as 40 under 40 by three separate organizations: University of Florida, Atlanta Business Chronicle, and Association for Value-Based Cancer Care.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: June 15, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 16 Product(s)

    INS 2022 Virtual Conference will provide a great alternative for those who are not able to attend the in-person event. Participants will have the ability to attend 15 select sessions virtually and on-demand. This option also enables CRNI®s to earn up to 30 recertification (RU) units. The virtual program will include the 5-hour veINS focus track on Monday, June 6 plus 10 additional one-hour sessions on Sunday, June 5.

    INS 2022 Virtual Conference will provide a great alternative for those who are not able to attend the in-person event. Participants will have the ability to attend 15 select sessions virtually and on-demand. This option also enables CRNI®s to earn up to 30 recertification (RU) units. The virtual program will include the 5-hour veINS focus track on Monday, June 6 plus 10 additional one-hour sessions on Sunday, June 5.  

  • Contains 3 Component(s), Includes Credits Recorded On: 05/18/2022

    ​There are many different forms of infusions that are administered to infants and children, and many are life-saving. However, they are also not without the potential for serious complications and morbidity. Infusion nurses are at the forefront of promoting safe, high-quality practices to prevent harm from this vital therapy. In this webinar, we will explore the strategies infusion nurses can employ to reduce harm to pediatric patients at their organization.

    There are many different forms of infusions that are administered to infants and children, and many are life-saving. However, they are also not without the potential for serious complications and morbidity. Infusion nurses are at the forefront of promoting safe, high-quality practices to prevent harm from this vital therapy. In this webinar, we will explore the strategies infusion nurses can employ to reduce harm to pediatric patients at their organization.

    Learning Objectives: At the conclusion of this webinar, learners will be able to: 

    ·      Describe the ethical duty of beneficence when caring for a patient receiving infusion therapy

    ·      Discuss two types of infusion injuries that have high-morbidity outcomes

    ·      List four strategies the infusion nurse can employ to reduce harm to the pediatric patient receiving infusion therapy at their organization

    Kristina Burger, DNP, APRN, CPNP-PC, CCRN, NPD-BC, LNC

    Dr. Kristina Burger has practiced pediatric nursing for 35 years and in a variety of settings from critical care to home care. She has provided extensive staff development on infusion therapy to all levels of nurses from new graduates to those providing home infusion services. She has also written numerous policies on infusion therapy and recently published a research paper testing the validity and reliability of a pediatric infiltration/extravasation staging tool with colleagues from Johns Hopkins All Children's Hospital.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: May 18, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 04/06/2022

    Infusion nurses play a vital role in inquiry work because they are uniquely able to identify opportunities for improvement in infusion therapy practice or potential patient safety problems. This webinar will provide an overview of inquiry and discuss the differences between the three types of inquiry including evidence-based practice (EBP), quality improvement (QI), and research. The basic evidence-based process will be examined, and participants will be introduced to three common EBP models. Resources to promote infusion nurse participation in inquiry and dissemination will also be explored.

    Infusion nurses play a vital role in inquiry work because they are uniquely able to identify opportunities for improvement in infusion therapy practice or potential patient safety problems. This webinar will provide an overview of inquiry and discuss the differences between the three types of inquiry including evidence-based practice (EBP), quality improvement (QI), and research. The basic evidence-based process will be examined, and participants will be introduced to three common EBP models. Resources to promote infusion nurse participation in inquiry and dissemination will also be explored.

    Learning objectives: At the completion of this webinar, learners will be able to:

    1.     Discuss the basic differences between evidence-based practice, quality improvement, and research

    2.     Describe the basic evidence-based practice process

    3.     State at least one common evidence-based practice model

    4.     Describe resources available to promote infusion nurse participation in inquiry and dissemination

    Genieveve Cline, PhD, DNP, APRN, NNP-BC, CNE, NPD-BC

    Assistant Professor, Director of the Education Concentration

    University of South Florida, College of Nursing

    Dr. Genieveve Cline is an assistant professor at the University of South Florida, College of Nursing, and the director of the education concentration. Dr. Cline graduated with her PhD as a nurse research scientist in 2018 from the University of South Florida, and received her Doctorate of Nursing Practice from the University of South Florida in 2009. She is certified as a neonatal nurse practitioner, an academic educator, and a nursing professional development specialist. She currently teaches research, evidence-based practice, organizational and systems leadership, and quality improvement in the graduate nursing program in addition to teaching the nurse educator curriculum. Prior to her current position, Dr. Cline was the director of nursing research and evidence-based practice at Johns Hopkins All Children's Hospital and taught multiple courses across the organization to prepare nurses for successful participation in inquiry. She regularly serves as a mentor for nurses completing research, evidence-based practice, and quality improvement projects. Her areas of research interest include interventions to improve clinical outcomes for infants with neonatal abstinence syndrome, and interventions to promote the utilization of science in health care.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: April 6, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 03/16/2022

    ​Many people do not understand what is happening with peripheral intravenous catheters (PIVCs), a seemingly innocuous device. Did you know that up to 69% of all PIVCs fail with an estimated excessive cost of $475,000 per 10,000 catheters used?—And the financial burden is only part of the story. Patient complications from PIVCs was number nine in the top 10 patient safety concerns in 2021, as identified by the ECRI Institute, one of the largest health care quality and safety entities in the world. To an observer, PIVCs often lie: we see no external signs and symptoms, and thus complications are often undetected. Yet when we look inside the vein, we see complications have begun, and we find the internal catheter positioning (the lie of the catheter) a contributing factor. Join us as we explore why the complications we see with PIVCs are late signs and symptoms of where the true problems lie.

    Many people do not understand what is happening with peripheral intravenous catheters (PIVCs), a seemingly innocuous device. Did you know that up to 69% of all PIVCs fail with an estimated excessive cost of $475,000 per 10,000 catheters used?—And the financial burden is only part of the story. Patient complications from PIVCs was number nine in the top 10 patient safety concerns in 2021, as identified by the ECRI Institute, one of the largest health care quality and safety entities in the world. To an observer, PIVCs often lie: we see no external signs and symptoms, and thus complications are often undetected. Yet when we look inside the vein, we see complications have begun, and we find the internal catheter positioning (the lie of the catheter) a contributing factor. Join us as we explore why the complications we see with PIVCs are late signs and symptoms of where the true problems lie.

    Learning Objectives:  At the conclusion of this presentation, learners will be able to:

    ·       Identify the prevalence of PIVC use and associated complications

    ·       Describe visually the impact of cannulation on vascular anatomy with use of case studies

    ·       Discuss the relationship between reported incidence of complications and actual practice

    ·       Summarize both the financial cost and patient outcomes involved with poor PIVC care

    ·       Discuss implementation in practice from the current INS Standards of Practice regarding PIVC placement and management

    S. Matthew Gibson, RN, CRNI®, VA-BC, CPUI

    CEO

    Vacllc

    Over the past decade, Matt has served national and local vascular access organizations, assumed leadership positions in multiple committees as a resident advisor, and been a published author in the area of vascular access. Currently Matt works as a vascular access consultant and speaker for various organizations. Matt is a certified registered nurse in infusion, is vascular access board certified, and is a certified PICC ultrasound user. He serves on the Association for Vascular Access (AVA) PIV Task Force and the AVA Public Policy Task Force, and is the CEO of Vascular Access Consulting LLC as well as the current president and founder of the Kentucky Indiana Vascular Access Network.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: March 16, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.